The Future of Pharamcovigilance is Digital
Digital PV Improves Case Processing by 30%.
The drug safety ecosystem and PV have become increasingly complex and costly with annual PV budgets tripling in less than 5 years. Non-compliant reporting on PV can cost Pharma companies up to billions of dollars in fines and lost opportunity. Adverse drug events can be deadly if not properly managed.
This webinar introduces Digital PV, an intelligent automation solution, which delivers end-to-end ICSR processes using a combination of RPA (Robotic Process Automation), AI (Artificial Intelligence) and ML (Machine Learning), in order to automate repetitive tasks thus freeing up employees to focus on higher-value work.